- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03179267
Detection of Deterioration by SNAP40 Versus Standard Monitoring in the ED (SNAP40ED)
Detection of Physiological Deterioration by the SNAP40 Wearable Device Compared to Standard Monitoring Devices in the Emergency Department
Study Overview
Detailed Description
As well as the potential of the SNAP40 device to improve patient safety, we believe that the SNAP40 device will increase ED efficiency, improve and increase use of resources and enable improved patient flow through the ED. Currently the only option for continuous monitoring or regular observations in the ED is to connect the patient to a standard monitor. Whilst these monitors can be portable they are not lightweight enough to allow the patient to be ambulatory within the ED and therefore require the patient to have a bed and a bed space or cubicle. This leads to lack of space within the ED, less cubicles (which allow privacy) free for performing history taking, examination and procedures, difficulty accessing patients and difficulty transporting them to areas where specialist tests can be performed (i.e. radiology and ECG). SNAP40 may remove the need for patients to be confined to beds and bed spaces (unless clinically required) freeing up space within the ED and allowing the ED care processes to occur much more freely increasing efficiency and speed of patient processing. This will undoubtedly lead to improved patient experiences around their ED and hospital journey.
The SNAP40 device also has the potential to free up resources, which can be used to improve patient care and experience in the ED. SNAP40 may reduce clinical staff time taken to record observations enabling them to provide patients with other aspects of care (i.e. analgesia and treatments) more regularly and in a timelier manner. Clinical staff may be able to spend more time with patients allowing better quality communication with them and their relatives. There will potentially be more time for traditional nursing care and personal care.
Whilst there are some other similar medical devices on the market (i.e. www.biovotion.com, www.sensium-healthcare.com, www.vitalconnect.com, http://www.caretakermedical.net) using wristbands, patches or finger cuff technology, currently none are being used in ED clinical practice.
This study will examine the SNAP40 device by comparing its performance to detect physiological deterioration against standard observations taken by clinical staff (nurses, doctors and clinical support workers) within the ED. The study will assess whether the device is able to detect physiological derangement sooner that standard monitoring devices.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Midlothian
-
Edinburgh, Midlothian, United Kingdom, EH16 4SA
- Royal Infirmary of Edinburgh
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Participant aged 16 years or over AND
- Participant triaged to Majors (High Dependency or Immediate Care) OR Participants who are stepped down from Resuscitation room care to High Dependency or Immediate Care
Exclusion Criteria:
- Participants under 16 years of age
- Previous participation in the study
- Participant in custody
- Participants deemed high risk for absconding by clinical staff
- Participants unable to communicate in English
- Participants who are triaged to immediate resuscitation. These participants may be considered for inclusion once immediate assessment and treatment have been initiated and they are stepped down to High Dependency (HD)/Immediate Care (IC) areas
- Patients with implantable defibrillators, pacemakers or neurostimulators will be excluded
- Patients who cannot have blood pressure measured in both arms e.g. patients with renal fistula, a Peripherally Inserted Central Catheter (PICC) line or who have had a lymph node clearance
Study Plan
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: SNAP40 monitor
All participants in the study will be fitted with the SNAP40 ambulatory monitoring device as well as usual monitoring as standard care
|
SNAP40 ambulatory monitoring device
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time to detection of deterioration
Time Frame: 4 hours
|
Time to detection of deterioration in an ED patient's vital sign physiology defined as an increase in NEWS score.
This would include a deterioration in blood pressure, pulse/heart rate, respiratory rate, skin temperature (SNAP40)/core temperature (Standard), oxygen saturation reading or movement (SNAP40)/GCS (Standard).
|
4 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Staff observation and responding to alarm times
Time Frame: 4 hours
|
Time ED staff spend performing a charting observations and responding to standard monitoring alarms.
|
4 hours
|
|
Percentage clinical escalation of care when deterioration detected.
Time Frame: 4 hours
|
Percentage clinical escalation of care when deterioration detected.
|
4 hours
|
|
Participants satisfaction
Time Frame: 4 hours
|
Participants rating of experience of both SNAP40 and current monitoring.
|
4 hours
|
|
Staff satisfaction
Time Frame: 4 hours
|
ED staff rating of experience of both SNAP40 and current monitoring.
|
4 hours
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Matt Reed, NHS Lothian
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 17/SS/0028
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Vital Signs
-
Nuralogix CorporationUniversity Health Network, Toronto; Hamilton Health Sciences CorporationNot yet recruiting
-
Oxehealth LimitedCentral and North West London NHS Foundation TrustCompleted
-
Dr. Behcet Uz Children's HospitalCompleted
-
Ain Shams UniversityCompleted
-
Rigshospitalet, DenmarkCompleted
-
LifeWatch Services, Inc.Completed
-
Tampere University HospitalTampere UniversityCompleted
-
Xim LimitedCompletedVital SignsUnited Kingdom
-
LifeWatch Services, Inc.Completed
Clinical Trials on SNAP40
-
Mayo ClinicSnap40 Ltd.CompletedRemote MonitoringUnited States